Anthracene derivatives

Details Anthracene derivatives Anthracene derivatives

1987-08-28

1989-02-07

Hollrah, Glennon H.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

2605011, 26050112, 26050118, 26050121, 560 5, 560257, 564341, 564366, 564387, 564391, 564426, 564427, 564440, 564442, 564443, 558413, 558414, 558422, 514577, 514653, 514908, C07C 9300, C07C 8778, C07C 8764

Patent

active

048032212

ABSTRACT:
The present invention relates to compounds of formula (I)

REFERENCES:
patent: 2530065 (1950-11-01), King
patent: 2574150 (1951-11-01), Kerwin et al.
patent: 3198802 (1965-08-01), Clark et al.
patent: 4511582 (1985-04-01), Bair
patent: 4530800 (1985-07-01), Bair
patent: 4532344 (1985-07-01), Bair
patent: 4551282 (1985-11-01), Bair
patent: 4719046 (1988-01-01), Bair
patent: 4719047 (1988-01-01), Bair
patent: 4719048 (1988-01-01), Bair
patent: 4719049 (1988-01-01), Bair
patent: 4719055 (1988-01-01), Bair
patent: 4720587 (1988-01-01), Bair
Investigational New Drugs 2, 1984, Bradley et al. pp. 59-70 "The Bender Tumor Colony-Forming Chemosensitivity Assay."
Dow Jones New Wire, 4/22/88 #160425-0097.
Hrabowska, M., et al., "Antitumo Activity of 1-Nitro-9 amino aeridix Perserative", Angneiun-Forsch/Drug No. 32(11), No. 9 (1982), 1013-1016.

Affiliated with

Also associated with

Rating

Anthracene derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anthracene derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthracene derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1085088